Trial Profile
A Randomised Placebo-Controlled Trial of Rasagiline in Parkinson Disease Patients With Symptoms of Apathy
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 12 Aug 2015
Price :
$35
*
At a glance
- Drugs Rasagiline (Primary)
- Indications Parkinson's disease
- Focus Therapeutic Use
- 07 Aug 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 28 Dec 2010 Planned End Date changed from 1 Oct 2009 to 1 Oct 2011 as reported by ClinicalTrials.gov.
- 15 Oct 2008 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.